Neuralink

New Capabilities

Conducting multinational clinical trials; FDA cleared a trial expansion on October 31, 2026

Two years after Noland Arbaugh became the first person to receive a Neuralink implant, the company says 21 people in four countries use its devices, as of January 2026. On October 31, 2026, U.S. regulators cleared a larger expansion of the trial, letting Neuralink implant more people at more surgical sites, with new hospital partners in several states.

Updated Nov 1

New Capabilities

As of May 2026: Developing Blindsight cortical visual prosthesis, FDA breakthrough designation received

Stanford researchers implanted a chip smaller than a Tic Tac under the retinas of 38 blind patients. A year later, 27 could read again, including some who read entire books. The PRIMA device, published October 20, 2025 in the New England Journal of Medicine, is the first prosthetic to restore functional vision to people with macular degeneration—the leading cause of irreversible blindness.

Updated May 19